We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 980 results
  1. Antineoplastics

    Article 29 October 2022
  2. Chromatin-Remodeled State in Lymphoma

    Purpose of Review

    Emerging evidence has shown that epigenetic derangements might drive and promote tumorigenesis in various types of malignancies and...

    Yuxuan Liu, Yulissa Gonzalez, Jennifer E. Amengual in Current Hematologic Malignancy Reports
    Article 06 September 2019
  3. Comprehensive characterization of the genetic landscape of familial Hirschsprung’s disease

    Background

    Hirschsprung’s disease (HSCR) is one of the most common congenital digestive tract malformations and can cause stubborn constipation or...

    Jun **ao, Lu-Wen Hao, ... Jie-**ong Feng in World Journal of Pediatrics
    Article Open access 01 March 2023
  4. Deciphering the Prognostic Significance of MYD88 and CD79B Mutations in Diffuse Large B-Cell Lymphoma: Insights into Treatment Outcomes

    Background

    The clinical and genetic characteristics, as well as treatment outcomes, of diffuse large B-cell lymphoma (DLBCL) patients with different MYD88...

    Zucheng **e, Yan Qin, ... Yuankai Shi in Targeted Oncology
    Article 21 April 2024
  5. Hippocampal delivery of neurotrophic factor-α1/carboxypeptidase E gene prevents neurodegeneration, amyloidosis, memory loss in Alzheimer’s Disease male mice

    Alzheimer’s Disease (AD) is a prevalent neurodegenerative disease characterized by tau hyperphosphorylation, Aβ1-42 aggregation and cognitive...

    Lan **ao, Xuyu Yang, ... Y. Peng Loh in Molecular Psychiatry
    Article Open access 28 June 2023
  6. Role of the ADCY9 gene in cardiac abnormalities of the Rubinstein-Taybi syndrome

    Background

    Rubinstein–Taybi syndrome (RTS) is a rare, congenital, plurimalformative, and neurodevelopmental disorder. Previous studies have reported...

    Yueheng Wu, Yu **a, ... Jian Zhuang in Orphanet Journal of Rare Diseases
    Article Open access 22 April 2020
  7. Characteristics and prognosis of EGFR mutations in small cell lung cancer patients in the NGS era

    Purpose

    Targeted therapy has not been effective for small cell lung cancer (SCLC) patients. Although some studies have reported on EGFR mutations in...

    **aohong **e, Guihuan Qiu, ... Ming Liu in Clinical and Translational Oncology
    Article Open access 12 July 2023
  8. Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6)

    Background

    There is growing evidence supporting multidisciplinary molecular tumor boards (MTB) in solid tumors whereas hematologic malignancies remain...

    Hanno M. Witte, Jörg Riedl, ... Niklas Gebauer in Targeted Oncology
    Article Open access 24 July 2023
  9. Neuroendocrine differentiation distinguishes basaloid variant of lung squamous cell carcinoma

    Background

    Neuroendocrine (NE) differentiation is widely studied in non-small cell lung carcinomas (NSCLC) however, its significance remains unclear...

    Kianoosh Keyhanian, William J. Phillips, ... Harmanjatinder S. Sekhon in Diagnostic Pathology
    Article Open access 10 May 2022
  10. Normal meninges harbor oncogenic somatic mutations in meningioma-driver genes

    Julien Boetto, Isabelle Plu, ... Matthieu Peyre in Acta Neuropathologica
    Article 26 September 2023
  11. Analysis of the genomic landscape of primary central nervous system lymphoma using whole-genome sequencing in Chinese patients

    Primary central nervous system lymphoma (PCNSL) is an uncommon non-Hodgkin’s lymphoma with poor prognosis. This study aimed to depict the genetic...

    **anggui Yuan, Teng Yu, ... Wenbin Qian in Frontiers of Medicine
    Article 07 July 2023
  12. Subsequent development of histiocytic sarcoma and follicular lymphoma: cytogenetics and next-generation sequencing analyses provide evidence for transdifferentiation of early common lymphoid precursor—a case report and review of literature

    Histiocytic sarcoma (HS) is a rare aggressive hematologic neoplasm that can be associated with low-grade B cell lymphoma. The development of both...

    Sarah Péricart, Charlotte Waysse, ... Solène Evrard in Virchows Archiv
    Article 05 December 2019
  13. Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib/II study

    Anti-PD-1 antibodies are a favorable treatment for relapsed or refractory extranodal natural killer T cell lymphoma (RR-ENKTL), however, the complete...

    Yan Gao, Haixia He, ... Huiqiang Huang in Signal Transduction and Targeted Therapy
    Article Open access 17 May 2024
  14. Analysis of mutation profiles in extranodal NK/T-cell lymphoma: clinical and prognostic correlations

    The molecular pathogenesis of extranodal NK/T-cell lymphoma (NKTCL) remains obscured despite the next-generation sequencing (NGS) studies explored on...

    Yu-Cheng Chang, Hui-Jen Tsai, ... Sung-Hsin Kuo in Annals of Hematology
    Article 27 April 2024
  15. Hyperdiploidy: the longest known, most prevalent, and most enigmatic form of acute lymphoblastic leukemia in children

    Hyperdiploidy is the largest genetic entity B-cell precursor acute lymphoblastic leukemia in children. The diagnostic hallmark of its two variants...

    Oskar A. Haas, Arndt Borkhardt in Leukemia
    Article Open access 20 October 2022
  16. Ocular manifestations of congenital anomalies of the kidney and urinary tract (CAKUT)

    Congenital anomalies of the kidney and urinary tract (CAKUT) are among the most common birth defects worldwide and a major cause of kidney failure in...

    James Virth, Heather G. Mack, ... Judy Savige in Pediatric Nephrology
    Article Open access 20 July 2023
  17. UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease

    UTX/KDM6A, a histone H3K27 demethylase and a key component of the COMPASS complex, is frequently lost or mutated in cancer; however, its tumor...

    Ola Rizq, Naoya Mimura, ... Atsushi Iwama in Leukemia
    Article Open access 17 May 2023
  18. Altered pathways and targeted therapy in double hit lymphoma

    High-grade B-cell lymphoma with translocations involving MYC and BCL2 or BCL6 , usually referred to as double hit lymphoma (DHL), is an aggressive...

    Yuxin Zhuang, **xin Che, ... Haiyan Yang in Journal of Hematology & Oncology
    Article Open access 18 March 2022
Did you find what you were looking for? Share feedback.